The use of depot naltrexone under legal coercion: The case for caution

Addiction

Volumn 103, Issue 12, 2008, Pages 1922-1924

  Hall, Wayne ^a   Capps, Benjamin ^b   Carter, Adrian ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Ethical issues; Heroin dependence; Implantable naltrexone; Legal coercion

Indexed keywords

BUPRENORPHINE; DISULFIRAM; METHADONE; NALTREXONE;

ADDICTION; ALCOHOLISM; DRUG IMPLANT; EDITORIAL; HEROIN DEPENDENCE; HUMAN; PERSUASIVE COMMUNICATION; PSYCHOTHERAPY;

COERCION; DELAYED-ACTION PREPARATIONS; HUMANS; NALTREXONE; NARCOTIC ANTAGONISTS; PERSONAL AUTONOMY; SUBSTANCE-RELATED DISORDERS;

EID: 55649106378     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2008.02370.x     Document Type: Editorial

References (18)

1. Sullivan M. A., Birkmayer F., Boyarsky B. K., Frances R. J., Fromson J. A., Galanter M. et al. Use of coercion in addiction treatment: clinical aspects. Am J Addict 2008 17 : 26 47.
2. Campbell N. C. Discovering Addiction: The Science and Politics of Substance Abuse Research. Ann Arbor : University of Michigan Press 2007.
3. Klag S., O'Callaghan F., Creed P. The use of legal coercion in the treatment of substance abusers: an overview and critical analysis of thirty years of research. Subst Use Misuse 2005 40 : 1777 95.
4. Wild T. C. Social control and coercion in addiction treatment: towards evidence-based policy and practice. Addiction 2006 101 : 40 9.
5. O'Brien C., Cornish J. W. Naltrexone for probationers and parolees. J Subst Abuse Treat 2006 31 : 107 11.
6. Caplan A. L. Ethical issues surrounding forced, mandated, or coerced treatment. J Subst Abuse Treat 2006 31 : 117 20.
7. Foddy B., Savulescu J. Addiction and autonomy: can addicted people consent to the prescription of their drug of addiction? Bioethics 2006 20 : 1 15.
8. Walker T. Giving addicts their drug of choice: the problem of consent. Bioethics 2008 22 : 314 20.
9. Carter A., Hall W. Informed consent to opioid agonist maintenance treatment: recommended ethical guidelines. Int J Drug Policy 2008 19 : 79 89.
10. Kirchmayer U., Davoli M., Verster A. Naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev 2003 issue 2 : CD001333.
11. Gibson A. E., Degenhardt L. J. Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records. Drug Alcohol Rev 2007 26 : 405 10.
12. Digiusto E., Shakeshaft A., Ritter A., O'Brien S., Mattick R. P. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addiction 2004 99 : 450 60.
13. Lobmaier P., Kornor H., Kunoe N., Bjorndal A. Sustained-release naltrexone for opioid dependence. Cochrane Database Syst Rev 2008 issue 2 : CD006140.
14. MacCoun R. Anticipating unintended consequences of vaccine-like immunotherapies and depot medications of addictive drug use. In : Harwood H. J., Myers T. G., editors. New Treatments for Addiction: Behavioral, Ethical, Legal and Social Questions. Washington, DC : National Academies Press 2004, p. 241 75.
15. Amato L., Davoli M., Perucci C. A., Ferri M., Faggiano F., Mattick R. P. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat 2005 28 : 321 9.
16. Presenza L. J. Naltrexone as a 'mandate' or as a choice: comments on 'judicially mandated naltrexone use by criminal offenders: a legal analysis J Subst Abuse Treat 2006 31 : 129 30.
17. Hall W. The role of legal coercion in the treatment of offenders with alcohol and heroin problems. Aust NZ J Criminol 1997 30 : 103 20.
18. Porter L., Arif A., Curran W. J. The Law and the Treatment of Drug- and Alcohol- Dependent Persons: A Comparative Study of Existing Legislation. Geneva : World Health Organization 1986.